Why did VTYX's operating profit improve in Q2 2024?

Ventyx Biosciences' operating profit for Q2 2024 was not reported, but its financial results for Q1 2024 show a reported loss of $31.93 million. VTYX's operating profit likely did not improve in Q2 2024, if it was negative or zero in Q1 2024, as the data does not provide information on an improvement. |code|Ticker|Name|Date|Operating Income YoY|Operating Income|market_code| |---|---|---|---|---|---|---| |VTYX|VTYX.O|Ventyx Biosciences|2023 Q3|-77.63564616902335|-5.4019E7|185| |VTYX|VTYX.O|Ventyx Biosciences|2023 Q4|-32.043746114282484|-4.6725E7|185| |VTYX|VTYX.O|Ventyx Biosciences|2024 Q1|0.9992293860775752|-3.8541E7|185| |VTYX|VTYX.O|Ventyx Biosciences|2024 Q2|40.034932201479926|-3.1929E7|185|